S&P 500   3,462.31 (+1.03%)
DOW   28,463.05 (+0.95%)
QQQ   285.70 (+0.67%)
AAPL   118.25 (+1.96%)
MSFT   215.48 (+0.59%)
FB   266.38 (+1.91%)
GOOGL   1,543.47 (+0.88%)
AMZN   3,229.06 (+0.68%)
TSLA   422.95 (-1.83%)
NVDA   546.35 (+1.19%)
BABA   310.24 (+1.62%)
CGC   18.96 (-4.29%)
GE   7.36 (+0.96%)
MU   53.89 (+2.39%)
AMD   81.86 (-0.17%)
T   26.94 (+0.22%)
F   7.81 (+2.90%)
ACB   4.41 (-6.37%)
GILD   60.39 (-0.30%)
NFLX   527.24 (-0.66%)
BA   168.35 (+0.74%)
BAC   24.31 (+2.49%)
DIS   124.55 (+0.26%)
S&P 500   3,462.31 (+1.03%)
DOW   28,463.05 (+0.95%)
QQQ   285.70 (+0.67%)
AAPL   118.25 (+1.96%)
MSFT   215.48 (+0.59%)
FB   266.38 (+1.91%)
GOOGL   1,543.47 (+0.88%)
AMZN   3,229.06 (+0.68%)
TSLA   422.95 (-1.83%)
NVDA   546.35 (+1.19%)
BABA   310.24 (+1.62%)
CGC   18.96 (-4.29%)
GE   7.36 (+0.96%)
MU   53.89 (+2.39%)
AMD   81.86 (-0.17%)
T   26.94 (+0.22%)
F   7.81 (+2.90%)
ACB   4.41 (-6.37%)
GILD   60.39 (-0.30%)
NFLX   527.24 (-0.66%)
BA   168.35 (+0.74%)
BAC   24.31 (+2.49%)
DIS   124.55 (+0.26%)
S&P 500   3,462.31 (+1.03%)
DOW   28,463.05 (+0.95%)
QQQ   285.70 (+0.67%)
AAPL   118.25 (+1.96%)
MSFT   215.48 (+0.59%)
FB   266.38 (+1.91%)
GOOGL   1,543.47 (+0.88%)
AMZN   3,229.06 (+0.68%)
TSLA   422.95 (-1.83%)
NVDA   546.35 (+1.19%)
BABA   310.24 (+1.62%)
CGC   18.96 (-4.29%)
GE   7.36 (+0.96%)
MU   53.89 (+2.39%)
AMD   81.86 (-0.17%)
T   26.94 (+0.22%)
F   7.81 (+2.90%)
ACB   4.41 (-6.37%)
GILD   60.39 (-0.30%)
NFLX   527.24 (-0.66%)
BA   168.35 (+0.74%)
BAC   24.31 (+2.49%)
DIS   124.55 (+0.26%)
S&P 500   3,462.31 (+1.03%)
DOW   28,463.05 (+0.95%)
QQQ   285.70 (+0.67%)
AAPL   118.25 (+1.96%)
MSFT   215.48 (+0.59%)
FB   266.38 (+1.91%)
GOOGL   1,543.47 (+0.88%)
AMZN   3,229.06 (+0.68%)
TSLA   422.95 (-1.83%)
NVDA   546.35 (+1.19%)
BABA   310.24 (+1.62%)
CGC   18.96 (-4.29%)
GE   7.36 (+0.96%)
MU   53.89 (+2.39%)
AMD   81.86 (-0.17%)
T   26.94 (+0.22%)
F   7.81 (+2.90%)
ACB   4.41 (-6.37%)
GILD   60.39 (-0.30%)
NFLX   527.24 (-0.66%)
BA   168.35 (+0.74%)
BAC   24.31 (+2.49%)
DIS   124.55 (+0.26%)
Log in
OTCMKTS:KIADF

Kiadis Pharma Short Interest Ratio and Short Volume

$1.85
0.00 (0.00 %)
(As of 10/19/2020 12:00 AM ET)
Add
Today's Range
$1.85
Now: $1.85
$1.85
50-Day Range
$1.85
MA: $2.02
$2.15
52-Week Range
$1.50
Now: $1.85
$3.42
VolumeN/A
Average Volume11,600 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Short Interest

Kiadis Pharma (OTCMKTS:KIADF) Short Interest Data

Current Short Volume:64,600 shares
Previous Short Volume:1,000 shares
Change Vs. Previous Month:+6,360.00%
Dollar Volume Sold Short:$0.00
Short Interest Ratio / Days to Cover:129.0
Last Record Date:September, 30 2020
Short Percent of Float:0.00%
Today's Trading Volume:0 shares
Average Trading Volume:11,600 shares
Today's Volume Vs. Average:-100.00%



Kiadis Pharma (OTCMKTS:KIADF) Short Interest History

DateShares Sold ShortDollar Volume Sold ShortPercentage ChangePercentage FloatDays to CoverPrice on Record Date
9/30/202064,600 $0.00 6,360.0%0.0%129.2$0.00
9/15/20201,000 $2,150.00 0.0%0.0%0$2.15
8/31/20201,000 $0.00 0.0%0.0%5$0.00
7/31/202013,900 $29,885.00 826.7%0.0%3$2.15
7/15/20201,500 $3,225.00 -93.5%0.0%3.8$2.15
6/30/202023,200 $0.00 0.0%0.0%77.3$0.00
5/29/20203,000 $5,400.00 0.0%0.0%0$1.80
4/30/20206,400 $0.00 36.2%0.0%64$0.00
4/15/20204,700 $0.00 27.0%0.0%0$0.00
3/31/20203,700 $8,325.00 -87.1%0.0%6.2$2.25
3/13/202028,600 $42,900.00 0.0%0.0%47.7$1.50
2/28/202028,600 $0.00 0.0%0.0%0$0.00
2/14/202028,600 $58,058.00 0.0%0.0%0$2.03
1/31/202028,600 $0.00 0.0%0.0%0$0.00
12/31/20192,000 $4,600.00 900.0%0.0%10$2.30

Kiadis Pharma (OTCMKTS:KIADF) Short Interest FAQ

speech bubbles
speech bubbles











What is Kiadis Pharma's current short interest?

Short interest is the volume of Kiadis Pharma shares that have been sold short but have not yet been covered or closed out. As of September 30th, traders have sold 64,600 shares of KIADF short. 0.00% of Kiadis Pharma's shares are currently sold short. View details.

What is a good short interest ratio for Kiadis Pharma?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Kiadis Pharma currently has a short interest ratio of 129.0.

Is Kiadis Pharma's short interest increasing or decreasing?

Kiadis Pharma saw a increase in short interest in the month of September. As of September 30th, there was short interest totaling 64,600 shares, an increase of 6,360.0% from the previous total of 1,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications Inc ($5.12 billion), Aon PLC ($3.76 billion), Clorox Co ($3.07 billion), ViacomCBS Inc. ($2.89 billion), Analog Devices, Inc. ($2.49 billion), Moderna, Inc. ($2.37 billion), Datadog ($2.29 billion), Uber Technologies, Inc. ($2.22 billion), Kroger Co ($2.20 billion), and Simon Property Group Inc ($1.88 billion). View all of the most shorted stocks.

What does it mean to sell short Kiadis Pharma stock?

Short selling KIADF is an investing strategy that aims to generate trading profit from Kiadis Pharma as its price is falling. To short Kiadis Pharma stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Kiadis Pharma will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Kiadis Pharma?

A short squeeze for Kiadis Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KIADF, which in turn drives the price of the stock up even further.

How often is Kiadis Pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KIADF, twice per month. The most recent reporting period available is September, 30 2020.


This page was last updated on 10/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.